+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Citeline - Market Research Reports

Citeline's analysis, insight and consultancy services span drug, device, company, clinical trial and market intelligence. All services are delivered by an authoritative team of industry experts in key markets around the globe.

From
From
New Year Present For Takeda As Shire Close Nears? - Product Thumbnail Image

New Year Present For Takeda As Shire Close Nears?

  • Newsletter
  • October 2026
  • 4 Pages
  • Global
From
From
From
Gene Therapy's Next Big Challenge: Manufacturing - Product Thumbnail Image

Gene Therapy's Next Big Challenge: Manufacturing

  • Newsletter
  • October 2026
  • 5 Pages
  • Global
From
Biosimilar Suffixes Appear Superfluous In Adverse Event Reporting - Product Thumbnail Image

Biosimilar Suffixes Appear Superfluous In Adverse Event Reporting

  • Newsletter
  • October 2026
  • 4 Pages
  • Global
From
From
DECIEM, Truly 'The Abnormal Beauty Company,' Faces Uncertain Future - Product Thumbnail Image

DECIEM, Truly 'The Abnormal Beauty Company,' Faces Uncertain Future

  • Newsletter
  • October 2026
  • 3 Pages
  • Global
From
Father of Humira, Greg Winter, Wins 2018 Nobel Prize For Chemistry - Product Thumbnail Image

Father of Humira, Greg Winter, Wins 2018 Nobel Prize For Chemistry

  • Newsletter
  • October 2026
  • 2 Pages
  • Global
From
From
Takeda To Press On With Core R&D Strategy Post-Shire - Product Thumbnail Image

Takeda To Press On With Core R&D Strategy Post-Shire

  • Newsletter
  • October 2026
  • 3 Pages
  • Global
From
From
From
From
R&D Heads At GSK & AZ Say Key To Success Lies In Smart Risk Taking - Product Thumbnail Image

R&D Heads At GSK & AZ Say Key To Success Lies In Smart Risk Taking

  • Newsletter
  • October 2026
  • 3 Pages
  • Global
From
From
From
From
From
Loading Indicator